112 related articles for article (PubMed ID: 808340)
21. The identification and significance of hypoxanthine in dialyzable transfer factor.
Kirkpatrick CH; Robinson LB; Smith TK
Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148
[No Abstract] [Full Text] [Related]
22. Transfer factor and possible applications in gynecology.
Freedman RS; Wharton JT; Rutledge F; Sinkovics JG
Am J Obstet Gynecol; 1978 Mar; 130(5):572-84. PubMed ID: 343596
[TBL] [Abstract][Full Text] [Related]
23. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
Udey MC; Jendrisak MD; Parker CW
J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
[TBL] [Abstract][Full Text] [Related]
24. Properties of human transfer factor from KLH-immunized donors: dissociation of dermal transfer and proliferation augmenting activities.
Burger DR; Vandenbark AA; Dunnick W; Kraybill WG; Vetto RM
J Reticuloendothel Soc; 1978 Oct; 24(4):385-402. PubMed ID: 712720
[No Abstract] [Full Text] [Related]
25. Restoration of T-lymphocyte deficiency with dialysable leucocyte extract.
Valdimarsson H; Hambleton G; Henry K; McConnell I
Clin Exp Immunol; 1974 Feb; 16(2):141-52. PubMed ID: 4549704
[TBL] [Abstract][Full Text] [Related]
26. Transfer factor--a lymphocyte cell surface component.
Schröder I; Lüneburg S
Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
[TBL] [Abstract][Full Text] [Related]
27. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients.
Saoudi A; Castedo M; Nochy D; Mandet C; Pasquier R; Druet P; Pelletier L
Eur J Immunol; 1995 Jul; 25(7):1972-9. PubMed ID: 7621873
[TBL] [Abstract][Full Text] [Related]
28. Transfer of reactivity with in vitro produced transfer factor in rhesus and owl monkeys.
Pizza G; Viza D; Ablashi DV; Faggioni A; Armstrong G; Levine PH; Phillips J; DeVinci C; Innocenti R
Lymphokine Res; 1985; 4(4):351-7. PubMed ID: 2995733
[TBL] [Abstract][Full Text] [Related]
29. Effect of dialysable leukocytes extracts on antibody-dependent cellular cytotoxicity and lymphocyte Fc receptors.
Nékám K; Láng I; Fekete B; Gergely P; Petrányi G
Acta Microbiol Acad Sci Hung; 1978; 25(3):191-7. PubMed ID: 696436
[TBL] [Abstract][Full Text] [Related]
30. Specific transfer factor protects mice against lethal challenge with herpes simplex virus.
Viza D; Vich JM; Phillips J; Rosenfeld F; Davies DA
Cell Immunol; 1986 Jul; 100(2):555-62. PubMed ID: 3019568
[TBL] [Abstract][Full Text] [Related]
31. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA
Intervirology; 1977; 8(4):240-9. PubMed ID: 194867
[TBL] [Abstract][Full Text] [Related]
32. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis.
Gröhn P; Anttila R; Krohn K
Scand J Rheumatol; 1976; 5(3):151-7. PubMed ID: 981991
[TBL] [Abstract][Full Text] [Related]
33. Human tonsil lymphocytes in the transfer of cell-mediated immunity.
Giannitsis DJ; Mootz W; Larovici A; Taubert W; Fuchs R
Cytobios; 1979; 24(95 96):181-4. PubMed ID: 527374
[TBL] [Abstract][Full Text] [Related]
34. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
Wilson GB; Fudenberg HH
J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
[TBL] [Abstract][Full Text] [Related]
35. Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.
Kirkpatrick CH; Ottenson EA; Smith TK; Wells SA; Burdick JF
Clin Exp Immunol; 1976 Mar; 23(3):414-28. PubMed ID: 947642
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte physiology and function.
Caldwell CW; Burningham RA
Mil Med; 1975 Dec; 140(12):846-52. PubMed ID: 640
[No Abstract] [Full Text] [Related]
37. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
Corley RB; Dawson JR; Amos DB
Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
39. Proliferation and lymphocyte stimulatory capacity of Theileria-infected lymphoblastoid cells before and after the elimination of intracellular parasites.
Pinder M; Kar S; Withey KS; Lundin LB; Roelants GE
Immunology; 1981 Sep; 44(1):51-60. PubMed ID: 6792058
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of rat lymphocyte proliferation by hydrocortisone during the induction of cell-mediated immunity in vitro.
Stavy L; Cohen IR; Feldman M
Transplantation; 1974 Feb; 17(2):173-9. PubMed ID: 4544081
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
